Clinical Trials Directory

Trials / Completed

CompletedNCT01698437

Magnetic Resonance (MR) Guided Focused Ultrasound in the Treatment of Brain Tumors

MR-guided Ultrasound-Neurosurgery for the Treatment of Malignant Brain Tumors

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
3 (actual)
Sponsor
University Children's Hospital, Zurich · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Focused Ultrasound Focused ultrasound is an attractive method for non-invasive thermal ablation of soft tissue tumors. Treatment begins by acquiring a series of MR images of the target organ. The physician then identifies a target volume in the MR images and delineates the treatment contours on the images. Therapy planning software calculates the parameters required to effectively treat the defined target volume. During the treatment an ultrasound transducer generates and focuses ultrasound energy to a focal point, called a sonication. The sonication raises the tissue temperature within a well-defined region to a degree, which causes thermal coagulation. MR images acquired during sonication provide a quantitative, real-time temperature map of the target area to confirm the location of the sonication and the size of the coagulated region. The sonication process is repeated at multiple adjacent points to cover the entire prescribed treatment volume.

Conditions

Interventions

TypeNameDescription
DEVICENon-invasive intervention with focused ultrasound (ExAblate 4000)Non-invasive brain intervention using MR-guided focused ultrasound

Timeline

Start date
2011-02-01
Primary completion
2016-05-01
Completion
2016-05-01
First posted
2012-10-03
Last updated
2016-06-03

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT01698437. Inclusion in this directory is not an endorsement.